Packaging

With some notable exceptions, most public comments received by FDA on its proposal to require unique device identifiers (UDI) support both the essential thrust and the details of the proposal, although individual companies sought various exceptions from it.In its comments, the Consumer Healthcare Products Association (CHPA) said it agrees with that part of the proposal that would exempt nonprescription Class 1 from UDI labeling and data reporting requirements.

byJim Dickinson